Trial intelligence / Profile preview

GnRHa, hCG, and hMG for Non-obstructive Azoospermia

NCT02544191Phase 2Unknown

Sponsor
Jinling Hospital
Start
Dec 2015
Primary completion
Dec 2017
Modality
Peptides, Recombinant Proteins and Enzymes, Small Molecules
Countries
1
01

Overview

A Phase 2 trial of goserelin, human chorionic gonadotropin, urofollitropin in nonobstructive azoospermia (NOA), sponsored by Jinling Hospital. Status: unknown.

02

Drugs

goserelinhuman chorionic gonadotropinurofollitropin
03

Conditions

nonobstructive azoospermia (NOA)

Beyond the preview

Go deeper on NCT02544191.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02544191.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call